SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Anthony J. Demetris, Adriana Zeevi, Jacqueline G. O’Leary, ABO-compatible liver allograft antibody-mediated rejection, Current Opinion in Organ Transplantation, 2015, 20, 3, 314

    CrossRef

  2. 2
    Paolo Carta, Lorenzo Di Maria, Leonardo Caroti, Elisa Buti, Giulia Antognoli, Enrico Eugenio Minetti, Anti-human leukocyte antigen DQ antibodies in renal transplantation: Are we underestimating the most frequent donor specific alloantibodies?, Transplantation Reviews, 2015, 29, 3, 135

    CrossRef

  3. 3
    Gonca E. Karahan, Frans H. J. Claas, Sebastiaan Heidt, Detecting the Humoral Alloimmune Response, Transplantation, 2015, 99, 5, 908

    CrossRef

  4. 4
    A.M. James Shapiro, Donor-specific Antibody in Pediatric Liver Transplantation—Identifying a Tree by Its Fruit, Transplantation, 2015, 99, 7, 1314

    CrossRef

  5. 5
    Laura J. Wozniak, Michelle J. Hickey, Robert S. Venick, Jorge H. Vargas, Douglas G. Farmer, Ronald W. Busuttil, Sue V. McDiarmid, Elaine F. Reed, Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation, Transplantation, 2015, 99, 7, 1416

    CrossRef

  6. 6
    Martine Neau-Cransac, Brigitte Le Bail, Gwendaline Guidicelli, Jonathan Visentin, Karine Moreau, Alice Quinart, Anna Boueilh, Christophe Laurent, Jean-Luc Taupin, Evolution of serum and intra-graft donor-specific anti-HLA antibodies in a patient with two consecutive liver transplantations, Transplant Immunology, 2015,

    CrossRef

  7. 7
    David H. Adams, Alberto Sanchez-Fueyo, Didier Samuel, From immunosuppression to tolerance, Journal of Hepatology, 2015, 62, 1, S170

    CrossRef

  8. 8
    J. G. O'Leary, H. Kaneku, N. Banuelos, L. W. Jennings, G. B. Klintmalm, P. I. Terasaki, Impact of IgG3 Subclass and C1q-Fixing Donor-Specific HLA Alloantibodies on Rejection and Survival in Liver Transplantation, American Journal of Transplantation, 2015, 15, 4
  9. 9
    Trygve Thorsen, Ulrika S. Dahlgren, Einar Martin Aandahl, Krzysztof Grzyb, Tom H. Karlsen, Kirsten M. Boberg, Lennart Rydberg, Christian Naper, Aksel Foss, William Bennet, Liver transplantation with deceased ABO-incompatible donors is life-saving but associated with increased risk of rejection and post-transplant complications, Transplant International, 2015, 28, 7
  10. 10
    Michael A. Zimmerman, Jennifer Schiller, Joohyun Kim, Alicia Martin, Motaz Selim, Trevor L. Nydam, David Cronin, Johnny C. Hong, Pathologic sequelae of allosensitization in liver transplantation, Journal of Surgical Research, 2015,

    CrossRef

  11. 11
    C.K. Burghuber, T.K. Roberts, S.J. Knechtle, The clinical relevance of alloantibody in liver transplantation, Transplantation Reviews, 2015, 29, 1, 16

    CrossRef

  12. 12
    Qiuheng Zhang, Raja Rajalingam, J. Michael Cecka, Elaine F. Reed, Transplantation of the Liver, 2015,

    CrossRef

  13. 13
    Anthony J. Demetris, Marta I. Minervini, Michael A. Nalesnik, Parmjeet Randhawa, Eizaburo Sasatomi, Transplantation of the Liver, 2015,

    CrossRef

  14. 14
    Justin Parekh, Nancy L. Ascher, John P. Roberts, Transplantation of the Liver, 2015,

    CrossRef

  15. 15
    Jacqueline G. O'Leary, S. Michelle Shiller, Christopher Bellamy, Michael A. Nalesnik, Hugo Kaneku, Linda W. Jennings, Kumiko Isse, Paul I. Terasaki, Göran B. Klintmalm, Anthony J. Demetris, Acute liver allograft antibody-mediated rejection: An inter-institutional study of significant histopathological features, Liver Transplantation, 2014, 20, 10
  16. 16
    T. Kheradmand, T.L. Anthony, R.C. Harland, G. Testa, J. Hart, J. Renz, H.S. Te, S.R. Marino, Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature, Human Immunology, 2014, 75, 6, 578

    CrossRef

  17. 17
    Jacqueline G. O'Leary, Hugo Kaneku, Anthony J. Demetris, John D. Marr, S. Michelle Shiller, Brian M. Susskind, Glenn W. Tillery, Paul I. Terasaki, Göran B. Klintmalm, Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss, Liver Transplantation, 2014, 20, 2
  18. 18
    Timucin Taner, Mark D. Stegall, Julie K. Heimbach, Antibody-mediated rejection in liver transplantation: Current controversies and future directions, Liver Transplantation, 2014, 20, 5
  19. 19
    Adeeb Salah, Masakazu Fujimoto, Atsushi Yoshizawa, Kimiko Yurugi, Aya Miyagawa-Hayashino, Shinji Sumiyoshi, Sachiko Minamiguchi, Shinji Uemoto, Taira Maekawa, Hironori Haga, Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation, Liver Transplantation, 2014, 20, 2
  20. 20
    Daniele Focosi, CDC Crossmatch and C1qSCREEN in Liver Transplantation, Transplantation, 2014, 97, 10, e61

    CrossRef

  21. 21
    Jacqueline G. O'Leary, Hugo Kaneku, Linda Jennings, Brian M. Susskind, Paul I. Terasaki, Göran B. Klintmalm, Donor-specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus–infected patients, Liver Transplantation, 2014, 20, 6
  22. 22
    Emma Perbos, Estelle Juinier, Gwendaline Guidicelli, Claire Dromer, Pierre Merville, Marc-Alain Billes, Jean-Luc Taupin, Martine Neau-Cransac, Evolution of donor-specific antibodies (DSA) and incidence of de novo DSA in solid organ transplant recipients after switch to everolimus alone or associated with low dose of calcineurin inhibitors, Clinical Transplantation, 2014, 28, 9
  23. 23
    Taizen Urahashi, Koichi Mizuta, Yoshiyuki Ihara, Yukihiro Sanada, Taiichi Wakiya, Naoya Yamada, Noriki Okada, Impact of post-transplant flow cytometric panel-reactive antibodies on late-onset hepatic venous outflow obstruction following pediatric living donor liver transplantation, Transplant International, 2014, 27, 3
  24. 24
    Geun Hong, Nam-Joon Yi, Suk-won Suh, Tae Yoo, Hyeyoung Kim, Min-Su Park, YoungRok Choi, Kyungbun Lee, Kwang-Woong Lee, Myoung Hee Park, Kyung-Suk Suh, Preoperative Selective Desensitization of Live Donor Liver Transplant Recipients Considering the Degree of T Lymphocyte Cross-Match Titer, Model for End-Stage Liver Disease Score, and Graft Liver Volume, Journal of Korean Medical Science, 2014, 29, 5, 640

    CrossRef

  25. 25
    A. Del Bello, N. Congy-Jolivet, F. Muscari, L. Lavayssière, L. Esposito, I. Cardeau-Desangles, J. Guitard, G. Dörr, B. Suc, J. P. Duffas, L. Alric, C. Bureau, M. Danjoux, C. Guilbeau-Frugier, A. Blancher, L. Rostaing, N. Kamar, Prevalence, Incidence and Risk Factors for Donor-Specific Anti-HLA Antibodies in Maintenance Liver Transplant Patients, American Journal of Transplantation, 2014, 14, 4
  26. 26
    Linwei Wu, Ngalei Tam, Ronghai Deng, Chenglin Wu, Philip Chen, Dongping Wang, Xiaoshun He, Steroid-resistant acute rejection after cadaveric liver transplantation: Experience from one single center, Clinics and Research in Hepatology and Gastroenterology, 2014, 38, 5, 592

    CrossRef

  27. 27
    J. G. O'Leary, A. J. Demetris, L. S. Friedman, H. M. Gebel, P. F. Halloran, A. D. Kirk, S. J. Knechtle, S. V. McDiarmid, A. Shaked, P. I. Terasaki, K. J. Tinckam, S. J. Tomlanovich, K. J. Wood, E. S. Woodle, A. A. Zachary, G. B. Klintmalm, The Role of Donor-Specific HLA Alloantibodies in Liver Transplantation, American Journal of Transplantation, 2014, 14, 4
  28. 28
    William Hanf, Claudine S. Bonder, P. Toby H. Coates, Transplant Glomerulopathy: The Interaction of HLA Antibodies and Endothelium, Journal of Immunology Research, 2014, 2014, 1

    CrossRef

  29. 29
    Michał Ciszek, Bartosz Foroncewicz, Krzysztof Mucha, Dorota Żochowska, Bogna Ziarkiewicz-Wróblewska, Marek Krawczyk, Leszek Pączek, Anti-HLA and Anti-MICA Antibodies in Liver Transplant Recipients: Effect on Long-Term Graft Survival, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  30. 30
    J. G. O'Leary, H. M. Gebel, R. Ruiz, R. A. Bray, J. D. Marr, X. J. Zhou, S. M. Shiller, B. M. Susskind, A. D. Kirk, G. B. Klintmalm, Class II Alloantibody and Mortality in Simultaneous Liver-Kidney Transplantation, American Journal of Transplantation, 2013, 13, 4
  31. 31
    Patricia Campbell, Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation, Current Opinion in Organ Transplantation, 2013, 18, 4, 463

    CrossRef

  32. 32
    Brian D. Tait, Caner Süsal, Howard M. Gebel, Peter W. Nickerson, Andrea A. Zachary, Frans H.J. Claas, Elaine F. Reed, Robert A. Bray, Patricia Campbell, Jeremy R. Chapman, P. Toby Coates, Robert B. Colvin, Emanuele Cozzi, Ilias I.N. Doxiadis, Susan V. Fuggle, John Gill, Denis Glotz, Nils Lachmann, Thalachallour Mohanakumar, Nicole Suciu-Foca, Suchitra Sumitran-Holgersson, Kazunari Tanabe, Craig J. Taylor, Dolly B. Tyan, Angela Webster, Adriana Zeevi, Gerhard Opelz, Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation, Transplantation Journal, 2013, 95, 1, 19

    CrossRef

  33. 33
    H. Kaneku, J. G. O'Leary, N. Banuelos, L. W. Jennings, B. M. Susskind, G. B. Klintmalm, P. I. Terasaki, De Novo Donor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients, American Journal of Transplantation, 2013, 13, 6
  34. 34
    H. Kaneku, J. G. O'Leary, N. Banuelos, L. W. Jennings, B. M. Susskind, G. B. Klintmalm, P. I. Terasaki, De NovoDonor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients, American Journal of Transplantation, 2013, n/a

    CrossRef

  35. 35
    Undine A. Gerlach, Katrin Vogt, Stephan Schlickeiser, Christian Meisel, Mathias Streitz, Desiree Kunkel, Christine Appelt, Stefanie Ahrlich, Nils Lachmann, Peter Neuhaus, Andreas Pascher, Birgit Sawitzki, Elevation of CD4+ Differentiated Memory T Cells Is Associated With Acute Cellular and Antibody-Mediated Rejection After Liver Transplantation, Transplantation Journal, 2013, 95, 12, 1512

    CrossRef

  36. 36
    Martina Koch, Christian Gräser, Anja Lehnhardt, Jörg M. Pollok, Nikolaus Kröger, Murielle Verboom, Friedrich Thaiss, Thomas Eiermann, Björn Nashan, Four-year allograft survival in a highly sensitized combined liver–kidney transplant patient despite unsuccessful anti-HLA antibody reduction with rituximab, splenectomy, and bortezomib, Transplant International, 2013, 26, 8
  37. 37
    Ulrike Schliesser, Martin Chopra, Andreas Beilhack, Christine Appelt, Simone Vogel, Julia Schumann, Ivo Panov, Katrin Vogt, Stephan Schlickeiser, Sven Olek, Kathryn Wood, Christine Brandt, Hans-Dieter Volk, Birgit Sawitzki, Generation of highly effective and stable murine alloreactive Treg cells by combined anti-CD4 mAb, TGF-β, and RA treatment, European Journal of Immunology, 2013, 43, 12
  38. 38
    Jacqueline G. O’Leary, Göran B. Klintmalm, Impact of donor-specific antibodies on results of liver transplantation, Current Opinion in Organ Transplantation, 2013, 18, 3, 279

    CrossRef

  39. 39
    Garrett R. Leonard, Hiroko Shike, Tadahiro Uemura, Justine L. Gaspari, Francesca M. Ruggiero, Riaz A. Shah, Thomas R. Riley, Zakiyah Kadry, Liver transplantation with a strongly positive crossmatch: Case study and literature review, Liver Transplantation, 2013, 19, 9
  40. You have free access to this content40
    Michael R. Lucey, Norah Terrault, Lolu Ojo, J. Eileen Hay, James Neuberger, Emily Blumberg, Lewis W. Teperman, Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation, Liver Transplantation, 2013, 19, 1
  41. 41
    Josh Levitsky, Gabriel C. Oniscu, Meeting report of the international liver transplantation society's 18th annual international congress: Hilton San Francisco Hotel, San Francisco, CA, May 16-19, 2012, Liver Transplantation, 2013, 19, 1
  42. 42
    M. Mengel, P. Campbell, H. Gebel, P. Randhawa, E. R. Rodriguez, R. Colvin, J. Conway, R. Hachem, P. F. Halloran, S. Keshavjee, P. Nickerson, C. Murphey, J. O'Leary, J. Reeve, K. Tinckam, E. F. Reed, Precision Diagnostics in Transplantation: From Bench to Bedside, American Journal of Transplantation, 2013, 13, 3
  43. 43
    Kayo Waki, Yasuhiko Sugawara, Koichi Mizuta, Michiko Taniguchi, Miyuki Ozawa, Masaru Hirata, Masumi Nozawa, Junichi Kaneko, Koki Takahashi, Takashi Kadowaki, Paul I. Terasaki, Norihiro Kokudo, Predicting Operational Tolerance in Pediatric Living-Donor Liver Transplantation by Absence of HLA Antibodies, Transplantation Journal, 2013, 95, 1, 177

    CrossRef

  44. 44
    Jacqueline G. O'Leary, Hugo Kaneku, Linda W. Jennings, Nubia Bañuelos, Brian M. Susskind, Paul I. Terasaki, Göran B. Klintmalm, Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation, Liver Transplantation, 2013, 19, 9
  45. 45
    Alexandru I. Musat, Courtney M. Pigott, Thomas M. Ellis, Rashmi M. Agni, Glen E. Leverson, Amy J. Powell, Katelyn R. Richards, Anthony M. D'Alessandro, Michael R. Lucey, Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation, Liver Transplantation, 2013, 19, 10
  46. 46
    Atsushi Yoshizawa, Hiroto Egawa, Kimiko Yurugi, Rie Hishida, Hiroaki Tsuji, Eiji Ashihara, Aya Miyagawa-Hayashino, Satoshi Teramukai, Taira Maekawa, Hironori Haga, Sinji Uemoto, Significance of Semiquantitative Assessment of Preformed Donor-Specific Antibody Using Luminex Single Bead Assay in Living Related Liver Transplantation, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  47. 47
    Anthony J. Demetris, Kumiko Isse, Tissue biopsy monitoring of operational tolerance in liver allograft recipients, Current Opinion in Organ Transplantation, 2013, 18, 3, 345

    CrossRef

  48. 48
    Andrew L. Singer, Dorry L. Segev, Transplantation: Alloantibodies in simultaneous liver–kidney transplantation, Nature Reviews Nephrology, 2013, 9, 7, 373

    CrossRef

  49. 49
    Oyedele A. Adeyi, Acute cellular rejection in intra-abdominal solid organ allografts – immunology under the light microscope, Diagnostic Histopathology, 2012, 18, 7, 297

    CrossRef

  50. 50
    Stefan G. Hübscher, Antibody-mediated rejection in the liver allograft, Current Opinion in Organ Transplantation, 2012, 1

    CrossRef

  51. 51
    F. Paterno, M. Shiller, G. Tillery, J. G. O’Leary, B. Susskind, J. Trotter, G. B. Klintmalm, Bortezomib for Acute Antibody-Mediated Rejection in Liver Transplantation, American Journal of Transplantation, 2012, 12, 9
  52. 52
    Hugo Kaneku, Jacqueline G. O'Leary, Michiko Taniguchi, Brian M. Susskind, Paul I. Terasaki, Göran B. Klintmalm, Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with Chronic rejection and graft loss after liver transplantation, Liver Transplantation, 2012, 18, 8
  53. 53
    Banu Sis, Endothelial molecules decipher the mechanisms and functional pathways in antibody-mediated rejection, Human Immunology, 2012, 73, 12, 1218

    CrossRef

  54. 54
    T. Oura, K. Yamashita, T. Suzuki, D. Fukumori, M. Watanabe, G. Hirokata, K. Wakayama, M. Taniguchi, T. Shimamura, T. Miura, K. Okimura, K. Maeta, H. Haga, K. Kubota, A. Shimizu, F. Sakai, H. Furukawa, S. Todo, Long-Term Hepatic Allograft Acceptance Based on CD40 Blockade by ASKP1240 in Nonhuman Primates, American Journal of Transplantation, 2012, 12, 7
  55. 55
    Philip A. Dyer, Frans H.J. Claas, Ilias I. Doxiadis, Denis Glotz, Craig J. Taylor, Minimising the clinical impact of the alloimmune response through effective histocompatibility testing for organ transplantation, Transplant Immunology, 2012, 27, 2-3, 83

    CrossRef

  56. 56
    Michael Mengel, Sufia Husain, Luis Hidalgo, Banu Sis, Phenotypes of antibody-mediated rejection in organ transplants, Transplant International, 2012, 25, 6
  57. 57
    Shishir Shetty, David H Adams, Stefan G Hubscher, Post-transplant liver biopsy and the immune response: lessons for the clinician, Expert Review of Clinical Immunology, 2012, 8, 7, 645

    CrossRef

  58. 58
    K. M. Abu-Elmagd, G. Wu, G. Costa, J. Lunz, L. Martin, D. A. Koritsky, N. Murase, W. Irish, A. Zeevi, Preformed and De Novo Donor Specific Antibodies in Visceral Transplantation: Long-Term Outcome With Special Reference to the Liver, American Journal of Transplantation, 2012, 12, 11
  59. 59
    T. Taner, M. J. Gandhi, S. O. Sanderson, C. R. Poterucha, S. R. De Goey, M. D. Stegall, J. K. Heimbach, Prevalence, Course and Impact of HLA Donor-Specific Antibodies in Liver Transplantation in the First Year, American Journal of Transplantation, 2012, 12, 6
  60. 60
    Aya Miyagawa-Hayashino, Atushi Yoshizawa, Yoichiro Uchida, Hiroto Egawa, Kimiko Yurugi, Satohiro Masuda, Sachiko Minamiguchi, Taira Maekawa, Shinji Uemoto, Hironori Haga, Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts, Liver Transplantation, 2012, 18, 11
  61. 61
    J. Lunz, K. M. Ruppert, M. M. Cajaiba, K. Isse, C. A. Bentlejewski, M. Minervini, M. A. Nalesnik, P. Randhawa, E. Rubin, E. Sasatomi, M. E. de Vera, P. Fontes, A. Humar, A. Zeevi, A. J. Demetris, Re-examination of the Lymphocytotoxic Crossmatch in Liver Transplantation: Can C4d Stains Help in Monitoring?, American Journal of Transplantation, 2012, 12, 1
  62. 62
    Sharif Ali, Adrian Ormsby, Veena Shah, Maria C. Segovia, Kristin L. Kantz, Sharon Skorupski, A. Bradley Eisenbrey, Meredith Mahan, Mary Ann Y. Huang, Significance of complement split product C4d in ABO-compatible liver allograft: Diagnosing utility in acute antibody mediated rejection, Transplant Immunology, 2012, 26, 1, 62

    CrossRef

  63. 63
    Tomasz Kozlowski, Kenneth Andreoni, John Schmitz, Paul Hideo Hayashi, Volker Nickeleit, Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: Diagnostic considerations in the evaluation of liver allografts, Liver Transplantation, 2012, 18, 6
  64. 64
    Jean Kwun, Pinar Bulut, Eugenia Kim, Wasim Dar, Byoungchol Oh, Ravi Ruhil, Neal Iwakoshi, Stuart J. Knechtle, The role of B cells in solid organ transplantation, Seminars in Immunology, 2012, 24, 2, 96

    CrossRef

  65. 65
    Sameh A. Fayek, The value of C4d deposit in post liver transplant liver biopsies, Transplant Immunology, 2012, 27, 4, 166

    CrossRef

  66. You have free access to this content66
    D. Briggs, D. H. Adams, Antibody-Associated Rejection in Liver Transplantation: Keep on Knocking, and the Door Will Be Opened to You, American Journal of Transplantation, 2011, 11, 9
  67. 67
    Christopher O. C. Bellamy, Complement C4d immunohistochemistry in the assessment of liver allograft biopsy samples: Applications and pitfalls, Liver Transplantation, 2011, 17, 7
  68. 68
    Roger Klein Moreira, Recurrent Hepatitis C and Acute Allograft Rejection, Advances In Anatomic Pathology, 2011, 18, 5, 393

    CrossRef

  69. 69
    Matthew H. Levine, Sandy Feng, Clinical Allograft Rejection Syndromes in Liver Transplantation,
  70. 70
    Anthony J. Demetris, Marta I. Minervini, Michael A. Nalesnik, Erin Rubin, Parmjeet Randhawa, Eizaburo Sasatomi, Histopathological Syndromes of Liver Allograft Rejection and Recurrent Disease,
  71. 71
    Robert A. Bray, Howard M. Gebel, Monitoring for HLA Antibody after Organ Transplantation,